Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. El-Serag H, Kanwal F, Ning J, Powell H, et al. Gut 2024 Feb 16:gutjnl-2024-332034. doi: 10.1136/gutjnl-2024-332034.

Read + Share

Amedeo Smart

Independent Medical Education

El-Serag H, Kanwal F, Ning J, Powell H, et al. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut 2024 Feb 16:gutjnl-2024-332034. doi: 10.1136/gutjnl-2024-332034.
PMID: 38365278